Heather Leigh Flannery is Global Lead of ConsenSys Health. She is also Co-Founder and Board Chair of Blockchain in Healthcare Global ("BiHG"), a new 501(c)6 trade association organized under the IEEE ISTO. She chairs the IEEE SA P2418.6 Standards Development Working Group (blockchain in healthcare and life sciences), serves as the FY19 Co-Chair of the global HIMSS Blockchain in Healthcare Task Force, and Chairs the Healthcare Special Interest Group at the Enterprise Ethereum Alliance (EEA).

Ms. Flannery is also an Innovation Fellow at EP3 Foundation, has served as Industry Faculty for the United States Department of Health and Human Services Office of the National Coordinator for Health IT (US HHS ONC) and is an active consultant, advisor, and keynote speaker.

Prior to ConsenSys, she founded and led Obesity Prevention, Policy, and Management, Inc. ("Obesity PPM"), an innovative provider of disease management, population health, research administration, and information technology managed services for health systems in the Americas, and an early adopter of distributed ledger technology.

Ms. Flannery has driven business model innovation via technology early adoption throughout her 25-year career as an entrepreneur, technologist, and strategist. She has consulted in the public sector in context of international development, bringing a global health perspective to her work. Focusing in the health sector since 2006, Ms. Flannery is a broad, lateral thinker who applies complex adaptive systems theory to advance the critical path to progress against large-scale macroscopic challenges.

Due to her personal life experience, Ms. Flannery is intrinsically motivated to impact population health and economic prosperity. She builds mission-driven organizations aligned by shared values: making measurable societal contributions, creating economically sustainable interventions, and prioritizing diversity and inclusion.

Molly is the first employee at Decent. She is focused on building a health insurance plan from scratch leveraging blockchain technology starting in Austin, Texas. Decent’s trailblazer plan is based around the Direct Primary Care Model which puts your relationship with your doctor at the center of your health.

She is a massive healthcare nerd, and has spent the last 20 or so years exploring the healthcare industry from many angles. She has worked in a variety of roles for doctors, health plans, and venture capital investors.

Molly hopes that her work with Decent will disrupt the status quo healthcare industry, and drive meaningful change to improve the lives of all. Molly lives in Seattle with her family and coaches roller derby in her spare time.

Sanjeev Wadhwa is the Founder, President and CEO of Life Singularity, a NJ-based AI/VR/Blockchain venture focused on Empathetic, AI-driven, individualized precision health by combining AI virtual assistants, real-time AR/VR healthcare interventions delivered via Blockchain-based smart agreements to realize our vision of "Predicting Health for a Better Life".

Life Singularity is a proud member of the Nvidia AI Inception Accelerator, Amazon AWS Activate and Google Cloud Startup Programs. In November 2018, Life Singularity was honored to be selected for MEDy (Medical Entrepreneurship and Disruption) awards competition at Healthcare Innovation Lab at Exponential Medicine. Life Singularity has been selected by Exponential Medicine as a case study in AI in Healthcare moonshot entrepreneurship and will be publicly launched on Singularity University's multiple entrepreneurship and branding channels.

Sanjeev is an Artificial Intelligence expert and has overseen development of Life Singularity’s AI platform and services and forged strategic partners with industry and academia. Sanjeev has more than 30 years of executive leadership experience in accelerating major transformations and development of game-changing commercial models, fueling organic and acquisitive growth through innovative collaborative models and disruptions.

Sanjeev recently was a Partner and a Americas leader of Ernst & Young’s Health Innovations and Life Sciences R&D practice. Prior to EY, Sanjeev was a Partner at CSC with Executive Leadership responsibilities for Healthcare Innovations, Life Sciences R&D, New Venture Development, Large Transformations, Strategy and M&A. Some of his work on large-scale Social Impact included guiding industry efforts to lead health innovations for Aging and Wellness at Self-Management Alliance at National Council on Aging and supporting a National Mental Health initiative – One Mind for Research – Honorable Congressman Patrick J. Kennedy's Moonshot project.

He is a social visionary and game-changer, who is a frequent keynote and plenary speaker on disruption, social impact, innovation, healthcare collaborations, ecosystem transformations, and has addressed congressional members, media and institutions. His work on “Power of Collective Intent” has received national recognition by Blues Health Plans, Brookings Institution, Self-Management Alliance at NCOA working with all agencies (NCI, NIH, CMS, CMMI) of Health and Human Services

Charlie Burgoyne is the founder and CEO of Valkyrie Intelligence, a consulting firm with domain expertise in applied science and strategy. Charlie leads a team of highly trained scientists and strategists to implement advanced analytics, machine learning, and artificial intelligence into products and processes.

Previously, Charlie held a variety of roles including principal director of data science at Frog Design, director of data science at Rosetta Stone, vice president of R&D for a government contracting firm
specializing in cybersecurity and machine learning, a research physicist for the DOE and NNSA, and a research astrophysicist for NASA in conjunction with George Washington University.

Charlie holds a master’s degree in astrophysics from Georgetown University and a bachelor’s in nuclear physics from George Washington University. He has a real passion for languages and speaks French, German, and Italian.

Andrew’s executive and entrepreneurial experience spans nearly 20 years in B2C and B2B, for startups and Fortune 500 companies. Andrew founded and sold three technology companies and today is the CEO and Founder of ClosedLoop.

ClosedLoop.ai uses the power of AI to identify at-risk patients and recommend the best interventions for each individual. They are currently working with the Mayo Clinic & Multiple Myeloma Research Foundation on a precision medicine research effort to study which maintenance therapy care pathways are most effective for which patients.

In 2012 Andrew co-founded the mobile software company Boxer. Boxer develops mobile productivity software for individuals and large corporations. Boxer was purchased by VMWare (one of the top 10 largest software companies in the world) in 2015. Prior to Boxer, Andrew co-founded the cyber security firm Ciphent in 2007. Ciphent grew to nearly 100 employees with 1,000 customers by 2010 before being acquired by Accuvant (now Optiv). Andrew also served as CEO of Bodkin Consulting Group where he worked with Fortune 500 brands and technology companies to define their interactive marketing strategies..

Andrew graduated Summa Cum Laude from Virgina Tech with a degree in Management Information Technology. Andrew lives in Austin TX with his two daughters and champion “Dock Dog” Sophie.